Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pneumonia | 11 | 2014 | 89 | 0.640 |
Why?
|
| Hospitals | 8 | 2014 | 77 | 0.600 |
Why?
|
| Quality Assurance, Health Care | 4 | 2012 | 64 | 0.490 |
Why?
|
| Medicare | 9 | 2012 | 126 | 0.420 |
Why?
|
| Community-Acquired Infections | 3 | 2008 | 31 | 0.400 |
Why?
|
| Surgical Wound Infection | 2 | 2011 | 108 | 0.390 |
Why?
|
| Peripheral Arterial Disease | 2 | 2025 | 144 | 0.380 |
Why?
|
| Healthcare Disparities | 3 | 2025 | 97 | 0.380 |
Why?
|
| Anti-Bacterial Agents | 5 | 2008 | 537 | 0.340 |
Why?
|
| Pneumonia, Bacterial | 1 | 2008 | 18 | 0.290 |
Why?
|
| Bacterial Infections | 1 | 2008 | 56 | 0.280 |
Why?
|
| Quality of Health Care | 3 | 2014 | 84 | 0.260 |
Why?
|
| United States | 15 | 2025 | 2247 | 0.230 |
Why?
|
| Limb Salvage | 1 | 2025 | 21 | 0.220 |
Why?
|
| Health Services, Indigenous | 1 | 2025 | 16 | 0.220 |
Why?
|
| Aged | 16 | 2025 | 5608 | 0.200 |
Why?
|
| Primary Health Care | 1 | 2025 | 169 | 0.200 |
Why?
|
| Hospitalization | 4 | 2014 | 201 | 0.190 |
Why?
|
| Diabetes Mellitus | 1 | 2025 | 215 | 0.190 |
Why?
|
| Myocardial Infarction | 4 | 2014 | 351 | 0.190 |
Why?
|
| Aged, 80 and over | 11 | 2014 | 2067 | 0.180 |
Why?
|
| Angioplasty, Balloon, Coronary | 2 | 2011 | 52 | 0.170 |
Why?
|
| Guideline Adherence | 4 | 2012 | 97 | 0.160 |
Why?
|
| Humans | 30 | 2025 | 28998 | 0.150 |
Why?
|
| Retrospective Studies | 10 | 2014 | 2644 | 0.150 |
Why?
|
| Male | 18 | 2025 | 13983 | 0.140 |
Why?
|
| Utilization Review | 1 | 1998 | 10 | 0.140 |
Why?
|
| Female | 22 | 2025 | 15690 | 0.140 |
Why?
|
| Patient Readmission | 2 | 2012 | 108 | 0.130 |
Why?
|
| Risk Assessment | 4 | 2025 | 631 | 0.130 |
Why?
|
| Vaccination | 3 | 2003 | 213 | 0.130 |
Why?
|
| Hospital Mortality | 3 | 2012 | 159 | 0.120 |
Why?
|
| Risk Factors | 5 | 2025 | 2134 | 0.110 |
Why?
|
| Treatment Outcome | 4 | 2025 | 2427 | 0.100 |
Why?
|
| Influenza, Human | 3 | 2003 | 95 | 0.100 |
Why?
|
| Pneumococcal Infections | 2 | 2002 | 24 | 0.090 |
Why?
|
| Time and Motion Studies | 1 | 2011 | 7 | 0.090 |
Why?
|
| Patient Discharge | 1 | 2012 | 109 | 0.090 |
Why?
|
| Fungemia | 1 | 2011 | 5 | 0.090 |
Why?
|
| Transportation of Patients | 1 | 2011 | 29 | 0.090 |
Why?
|
| Candida | 1 | 2011 | 23 | 0.090 |
Why?
|
| Candidiasis | 1 | 2011 | 27 | 0.090 |
Why?
|
| Quality Indicators, Health Care | 4 | 2014 | 54 | 0.090 |
Why?
|
| Cross Infection | 1 | 2011 | 37 | 0.090 |
Why?
|
| Coronary Artery Bypass | 1 | 2011 | 68 | 0.080 |
Why?
|
| HIV Infections | 5 | 1994 | 165 | 0.080 |
Why?
|
| Time Factors | 6 | 2012 | 1619 | 0.080 |
Why?
|
| Risk | 1 | 2010 | 138 | 0.080 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2010 | 38 | 0.080 |
Why?
|
| HIV-1 | 4 | 1994 | 59 | 0.080 |
Why?
|
| Fluoroquinolones | 1 | 2008 | 15 | 0.070 |
Why?
|
| Cephalosporins | 1 | 2008 | 18 | 0.070 |
Why?
|
| Macrolides | 1 | 2008 | 19 | 0.070 |
Why?
|
| Nursing Homes | 1 | 2008 | 51 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2008 | 210 | 0.070 |
Why?
|
| Middle Aged | 7 | 2025 | 7428 | 0.070 |
Why?
|
| Adult | 7 | 2025 | 8048 | 0.070 |
Why?
|
| Anti-Infective Agents | 1 | 2008 | 78 | 0.070 |
Why?
|
| Drug Utilization Review | 1 | 2007 | 7 | 0.070 |
Why?
|
| Severity of Illness Index | 2 | 2025 | 466 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2025 | 1004 | 0.060 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2008 | 177 | 0.060 |
Why?
|
| Influenza Vaccines | 2 | 2006 | 55 | 0.060 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 1994 | 47 | 0.060 |
Why?
|
| HIV Seropositivity | 5 | 1994 | 11 | 0.060 |
Why?
|
| Cohort Studies | 6 | 2011 | 898 | 0.060 |
Why?
|
| Physicians | 1 | 2006 | 83 | 0.060 |
Why?
|
| Prevalence | 1 | 2025 | 521 | 0.050 |
Why?
|
| Logistic Models | 3 | 2011 | 415 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 3 | 2012 | 249 | 0.050 |
Why?
|
| Inpatients | 1 | 2002 | 60 | 0.050 |
Why?
|
| Heart Failure | 2 | 2014 | 253 | 0.040 |
Why?
|
| Oklahoma | 2 | 2001 | 1058 | 0.040 |
Why?
|
| Democratic Republic of the Congo | 6 | 1994 | 8 | 0.030 |
Why?
|
| Age Distribution | 1 | 1998 | 75 | 0.030 |
Why?
|
| Sex Distribution | 1 | 1998 | 78 | 0.030 |
Why?
|
| Population Surveillance | 1 | 1998 | 87 | 0.030 |
Why?
|
| Health Care Surveys | 2 | 2011 | 69 | 0.030 |
Why?
|
| Acquired Immunodeficiency Syndrome | 3 | 1994 | 22 | 0.030 |
Why?
|
| Case-Control Studies | 3 | 2011 | 739 | 0.030 |
Why?
|
| Hydrocarbons | 1 | 1996 | 41 | 0.030 |
Why?
|
| Adolescent | 3 | 2011 | 3223 | 0.030 |
Why?
|
| Kidney Diseases | 1 | 1996 | 61 | 0.030 |
Why?
|
| Environmental Exposure | 1 | 1996 | 53 | 0.030 |
Why?
|
| Joint Commission on Accreditation of Healthcare Organizations | 1 | 2014 | 2 | 0.030 |
Why?
|
| Young Adult | 2 | 2011 | 2842 | 0.030 |
Why?
|
| African Americans | 2 | 2009 | 353 | 0.030 |
Why?
|
| Poliovirus Vaccine, Oral | 1 | 1993 | 2 | 0.030 |
Why?
|
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 1993 | 3 | 0.020 |
Why?
|
| BCG Vaccine | 1 | 1993 | 14 | 0.020 |
Why?
|
| Diarrhea, Infantile | 1 | 1992 | 6 | 0.020 |
Why?
|
| Health Services Research | 1 | 2012 | 45 | 0.020 |
Why?
|
| Surgical Procedures, Operative | 1 | 2012 | 49 | 0.020 |
Why?
|
| Insurance Claim Reporting | 1 | 2011 | 3 | 0.020 |
Why?
|
| Malaria | 1 | 1991 | 18 | 0.020 |
Why?
|
| Health Status | 1 | 2012 | 149 | 0.020 |
Why?
|
| Plasmodium falciparum | 1 | 1991 | 19 | 0.020 |
Why?
|
| Survival Rate | 1 | 2012 | 433 | 0.020 |
Why?
|
| Prognosis | 1 | 2012 | 812 | 0.020 |
Why?
|
| Pennsylvania | 1 | 2009 | 11 | 0.020 |
Why?
|
| Registries | 1 | 2011 | 398 | 0.020 |
Why?
|
| Prospective Studies | 4 | 1994 | 1283 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2003 | 288 | 0.020 |
Why?
|
| Multilevel Analysis | 1 | 2008 | 8 | 0.020 |
Why?
|
| Drug Utilization | 1 | 2008 | 28 | 0.020 |
Why?
|
| Infant, Newborn | 4 | 1994 | 924 | 0.020 |
Why?
|
| Algorithms | 1 | 2011 | 431 | 0.020 |
Why?
|
| Patient Selection | 1 | 2008 | 151 | 0.020 |
Why?
|
| Pregnancy | 4 | 1994 | 1260 | 0.020 |
Why?
|
| Medical Records | 1 | 2006 | 52 | 0.020 |
Why?
|
| Pneumococcal Vaccines | 1 | 2006 | 20 | 0.010 |
Why?
|
| Length of Stay | 1 | 2006 | 246 | 0.010 |
Why?
|
| Hospital Costs | 1 | 2004 | 31 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2004 | 303 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2001 | 104 | 0.010 |
Why?
|
| Age Factors | 1 | 2002 | 740 | 0.010 |
Why?
|
| Infant | 2 | 1992 | 1049 | 0.010 |
Why?
|
| Occupational Exposure | 1 | 1996 | 28 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1996 | 274 | 0.010 |
Why?
|
| Life Tables | 1 | 1994 | 6 | 0.010 |
Why?
|
| Diseases in Twins | 1 | 1994 | 4 | 0.010 |
Why?
|
| Fathers | 1 | 1994 | 15 | 0.010 |
Why?
|
| Sexual Partners | 1 | 1994 | 25 | 0.010 |
Why?
|
| Family Health | 1 | 1994 | 71 | 0.010 |
Why?
|
| Parity | 1 | 1994 | 50 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 1993 | 81 | 0.010 |
Why?
|
| Antibodies, Bacterial | 1 | 1993 | 103 | 0.010 |
Why?
|
| Nutritional Status | 1 | 1992 | 80 | 0.010 |
Why?
|
| Feces | 1 | 1992 | 117 | 0.010 |
Why?
|
| Mothers | 1 | 1993 | 126 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 1996 | 1011 | 0.010 |
Why?
|
| HIV Seroprevalence | 1 | 1990 | 1 | 0.010 |
Why?
|
| Serologic Tests | 1 | 1990 | 19 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1990 | 211 | 0.000 |
Why?
|
| Longitudinal Studies | 1 | 1991 | 430 | 0.000 |
Why?
|
| AIDS Serodiagnosis | 1 | 1989 | 1 | 0.000 |
Why?
|
| Abortion, Spontaneous | 1 | 1989 | 17 | 0.000 |
Why?
|
| Infant Mortality | 1 | 1989 | 15 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 1990 | 524 | 0.000 |
Why?
|
| Pregnancy Outcome | 1 | 1989 | 131 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 1989 | 285 | 0.000 |
Why?
|
| Animals | 1 | 1991 | 10715 | 0.000 |
Why?
|